Equities analysts expect Manhattan Associates, Inc. (NASDAQ:MANH) to report sales of $142.87 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Manhattan Associates’ earnings, with estimates ranging from $141.80 million to $144.80 million. Manhattan Associates reported sales of $152.88 million in the same quarter last year, which would suggest a negative year over year growth rate of 6.5%. The company is expected to issue its next earnings report on Tuesday, October 23rd.
On average, analysts expect that Manhattan Associates will report full-year sales of $554.29 million for the current fiscal year, with estimates ranging from $553.50 million to $555.85 million. For the next financial year, analysts forecast that the firm will report sales of $541.80 million per share, with estimates ranging from $537.40 million to $548.87 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Manhattan Associates.
Manhattan Associates (NASDAQ:MANH) last announced its quarterly earnings data on Tuesday, July 24th. The software maker reported $0.47 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.06. Manhattan Associates had a net margin of 18.87% and a return on equity of 68.14%. The company had revenue of $141.90 million for the quarter, compared to the consensus estimate of $140.42 million. During the same period in the prior year, the firm posted $0.50 EPS. The company’s quarterly revenue was down 7.9% compared to the same quarter last year.
A number of brokerages have commented on MANH. BidaskClub raised shares of Manhattan Associates from a “hold” rating to a “buy” rating in a research report on Wednesday, June 13th. ValuEngine downgraded shares of Manhattan Associates from a “hold” rating to a “sell” rating in a research report on Saturday, May 26th. Zacks Investment Research downgraded shares of Manhattan Associates from a “hold” rating to a “sell” rating in a research report on Friday, July 27th. Benchmark raised shares of Manhattan Associates from a “hold” rating to a “buy” rating and set a $65.00 target price on the stock in a research report on Friday, June 15th. Finally, TheStreet raised shares of Manhattan Associates from a “c+” rating to a “b-” rating in a research report on Friday, July 6th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Manhattan Associates has an average rating of “Buy” and a consensus price target of $60.00.
Shares of NASDAQ:MANH traded up $0.50 during trading hours on Friday, reaching $58.00. The stock had a trading volume of 225,000 shares, compared to its average volume of 583,526. Manhattan Associates has a 1 year low of $39.10 and a 1 year high of $58.64. The company has a market cap of $3.74 billion, a PE ratio of 33.52 and a beta of 1.26.
In related news, Director John J. Huntz, Jr. sold 2,000 shares of the stock in a transaction on Friday, August 24th. The shares were sold at an average price of $56.42, for a total value of $112,840.00. Following the transaction, the director now directly owns 72,636 shares of the company’s stock, valued at approximately $4,098,123.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Edmond Eger sold 2,820 shares of the stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $52.59, for a total transaction of $148,303.80. Following the completion of the transaction, the director now directly owns 9,376 shares in the company, valued at $493,083.84. The disclosure for this sale can be found here. Insiders sold a total of 12,560 shares of company stock worth $646,905 over the last ninety days. Insiders own 0.99% of the company’s stock.
A number of large investors have recently modified their holdings of MANH. FDx Advisors Inc. boosted its stake in Manhattan Associates by 6.5% during the 1st quarter. FDx Advisors Inc. now owns 42,921 shares of the software maker’s stock worth $1,798,000 after purchasing an additional 2,607 shares during the period. Wells Fargo & Company MN boosted its stake in Manhattan Associates by 0.5% during the 1st quarter. Wells Fargo & Company MN now owns 1,125,623 shares of the software maker’s stock worth $47,141,000 after purchasing an additional 5,995 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Manhattan Associates during the 1st quarter worth $784,000. Alps Advisors Inc. boosted its stake in Manhattan Associates by 51.7% during the 1st quarter. Alps Advisors Inc. now owns 33,073 shares of the software maker’s stock worth $1,385,000 after purchasing an additional 11,267 shares during the period. Finally, Mackay Shields LLC acquired a new stake in Manhattan Associates during the 1st quarter worth $4,897,000.
About Manhattan Associates
Manhattan Associates, Inc develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company provides supply chain solutions, including distribution management, transportation management, and visibility solutions; omni-channel solutions; and inventory optimization and planning solutions.
Recommended Story: Marijuana Stocks Investing Considerations
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Manhattan Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Associates and related companies with MarketBeat.com's FREE daily email newsletter.